JPH09506346A - 神経弛緩薬afsとしてのn−置換されたアザビシクロアルカン誘導体 - Google Patents
神経弛緩薬afsとしてのn−置換されたアザビシクロアルカン誘導体Info
- Publication number
- JPH09506346A JPH09506346A JP7515382A JP51538295A JPH09506346A JP H09506346 A JPH09506346 A JP H09506346A JP 7515382 A JP7515382 A JP 7515382A JP 51538295 A JP51538295 A JP 51538295A JP H09506346 A JPH09506346 A JP H09506346A
- Authority
- JP
- Japan
- Prior art keywords
- cis
- fluorophenyl
- exo
- mmol
- ethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D497/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D497/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D497/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Ink Jet (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.式I [式中、Bは、窒素原子1個及び/又は酸素原子1個を含有し、二重結合1個 を有していても良い3−、5−又は6−員環であり、R1は、置換されていない か又はハロゲン原子又はC1〜C4−アルキル、トリフルオルメチル、ヒドロキシ 、C1〜C4−アルコキシ、アミノ、モノメチルアミノ、ジメチルアミノ、シアノ 又はニトロ基によりモノ−又はジ置換されているフェニル基であり、R2は、水 素原子又はC1〜C4−アルキル基であり、nは2、3又は4の数であり、Aは水 素原子又は基: −CO−R5又は−NR6−CO−R7 (式中、R5は、置換されていないか又は弗素、塩素、臭素又はヒドロキシル 、ニトロ、アミノ、C1〜4−アルカノイルアミノ、C1〜4−アルキルアミノ、C1〜4 −アルキル又はメトキシ基によりモノ−又はジ置換されているフェニル基又 は置換されていないか又は弗素又は塩素により置換されているナフチル基であり 、R6は、水素原子又はメチル基 であり、R7は、弗素、塩素、臭素、C1〜C4−アルキル、ヒドロキシル又はメ トキシによりモノ−又はジ置換されているか又はニトロ、シアノ、トリフルオル メチル、アミノ、C1〜C4−アルキルアミノ又はジ−C1〜C4−アルキルアミノ によりモノ置換されているフェニル基又は置換されていないか又は弗素、塩素又 はニトロにより置換されているチエニル、ナフチル、ベンゾチエニル又はインデ ニル基である)の一つである]のN−置換された3−アザビシクロアルカン誘導 体及びその生理的に認容性の酸との塩。 2.病気の治療に使用するための請求項1に記載の式Iの化合物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4341403A DE4341403A1 (de) | 1993-12-04 | 1993-12-04 | N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung |
DE4341403.6 | 1993-12-04 | ||
PCT/EP1994/003913 WO1995015327A1 (en) | 1993-12-04 | 1994-11-26 | N-substituted azabicycloalkane derivatives as neuroleptika asf |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH09506346A true JPH09506346A (ja) | 1997-06-24 |
JP3935201B2 JP3935201B2 (ja) | 2007-06-20 |
Family
ID=6504205
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP51538295A Expired - Fee Related JP3935201B2 (ja) | 1993-12-04 | 1994-11-26 | 神経弛緩薬afsとしてのn−置換されたアザビシクロアルカン誘導体 |
Country Status (13)
Country | Link |
---|---|
US (1) | US5703091A (ja) |
EP (1) | EP0731802B1 (ja) |
JP (1) | JP3935201B2 (ja) |
AT (1) | ATE194620T1 (ja) |
AU (1) | AU680583B2 (ja) |
BR (1) | BR9408246A (ja) |
DE (2) | DE4341403A1 (ja) |
ES (1) | ES2148476T3 (ja) |
FI (1) | FI113644B (ja) |
IL (1) | IL111861A (ja) |
NO (1) | NO306346B1 (ja) |
TW (1) | TW285667B (ja) |
WO (1) | WO1995015327A1 (ja) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006513256A (ja) * | 2002-08-14 | 2006-04-20 | アボット・ラボラトリーズ | 中枢神経系活性剤であるアザビシクロ化合物 |
JP2008535886A (ja) * | 2005-04-14 | 2008-09-04 | グラクソ グループ リミテッド | ドーパミンd3受容体のモジュレーターとしての3−(1,2,4−トリアゾール−3−イルアルキル)アザビシクロ(3.1.0)ヘキサン誘導体 |
JP2013542929A (ja) * | 2010-09-28 | 2013-11-28 | パナセア バイオテック リミテッド | 新規ビシクロ環化合物 |
JP2016536348A (ja) * | 2013-09-26 | 2016-11-24 | ラック・セラピューティクス,インコーポレーテッド | Nr2bの選択的オクタヒドロ−シクロペンタ[c]ピロール負調節因子 |
WO2018021447A1 (ja) * | 2016-07-28 | 2018-02-01 | 塩野義製薬株式会社 | ドーパミンd3受容体拮抗作用を有する含窒素縮環化合物 |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19848521A1 (de) * | 1998-10-21 | 2000-04-27 | Basf Ag | Verfahren zur Herstellung von (+)-exo-6-Phenyl-3-azabicyclo-[3.2.0]heptanen |
DE19854147A1 (de) * | 1998-11-24 | 2000-05-25 | Basf Ag | Verwendung von N-substituierten Azabicycloalkan-Derivaten zur Verwendung bei der Bekämpfung der Cocainsucht |
TWI244481B (en) | 1998-12-23 | 2005-12-01 | Pfizer | 3-azabicyclo[3.1.0]hexane derivatives useful in therapy |
GB9912415D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
GB9912410D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
GB9912413D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
GB9912417D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
GB9912416D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
GB9912411D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
US6784200B2 (en) * | 2000-10-13 | 2004-08-31 | Bristol-Myers Squibb Pharma Company | Bicyclic and tricyclic amines as modulators of chemokine receptor activity |
CA2386049A1 (en) | 1999-10-15 | 2001-04-26 | Daniel S. Gardner | Bicyclic and tricyclic amines as modulators of chemokine receptor activity |
GB0015562D0 (en) * | 2000-06-23 | 2000-08-16 | Pfizer Ltd | Heterocycles |
SE0100326D0 (sv) | 2001-02-02 | 2001-02-02 | Astrazeneca Ab | New compounds |
MXPA03008109A (es) * | 2001-03-07 | 2003-12-12 | Pfizer Prod Inc | Moduladores de la actividad de receptores de quimiocinas. |
DE60231341D1 (de) * | 2002-08-23 | 2009-04-09 | Ranbaxy Lab Ltd | Fluor- und sulfonylaminohaltige, 3,6-disubstituierptorantagonisten |
EP1572648B1 (en) * | 2002-12-10 | 2008-07-09 | Ranbaxy Laboratories, Ltd. | 3,6-disubstituted azabicyclo (3.1.0)-hexane derivatives as muscarinic receptor antagonists |
FR2866647B1 (fr) | 2004-02-20 | 2006-10-27 | Servier Lab | Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
DE602005004144T2 (de) | 2004-06-09 | 2009-01-29 | F. Hoffmann-La Roche Ag | Octahydropyrroloä3,4-cüpyrrolderivate und deren verwendung als antivirale mittel |
US7665658B2 (en) | 2005-06-07 | 2010-02-23 | First Data Corporation | Dynamic aggregation of payment transactions |
EP1849771A1 (en) * | 2006-04-28 | 2007-10-31 | Laboratorios Del Dr. Esteve, S.A. | Bicyclic tetrahydropyrrole compounds |
EP1849772A1 (en) * | 2006-04-28 | 2007-10-31 | Laboratorios Del Dr. Esteve, S.A. | Bicyclic tetrahydropyrrole compounds |
EP2029536B1 (en) | 2006-04-28 | 2013-08-28 | Laboratorios Del. Dr. Esteve, S.A. | Bicyclic tetrahydropyrrole compounds |
GB0625198D0 (en) * | 2006-12-18 | 2007-01-24 | Glaxo Group Ltd | Chemical compounds |
GB0809479D0 (en) * | 2008-05-23 | 2008-07-02 | Glaxo Group Ltd | Novel compounds |
EP2595989B1 (en) | 2010-05-06 | 2016-07-13 | Vertex Pharmaceuticals Incorporated | Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels |
WO2012071369A2 (en) | 2010-11-24 | 2012-05-31 | The Trustees Of Columbia University In The City Of New York | A non-retinoid rbp4 antagonist for treatment of age-related macular degeneration and stargardt disease |
PT2670752E (pt) | 2011-02-02 | 2016-06-14 | Vertex Pharma | Piperidinamidas pirrolopirazina-espirocíclicas como moduladores de canais iónicos |
US10385070B2 (en) | 2011-02-18 | 2019-08-20 | Vertex Pharmaceuticals Incorporated | Chroman-spirocyclic piperidine amides as modulators of ion channels |
CN103517910B (zh) | 2011-03-14 | 2016-12-14 | 沃泰克斯药物股份有限公司 | 作为离子通道调节剂的吗啉-螺环哌啶酰胺 |
WO2013166037A1 (en) | 2012-05-01 | 2013-11-07 | The Trustees Of Columbia University In The City Of New York | Non-retinoid antagonists for treatment of eye disorders |
WO2014151936A1 (en) | 2013-03-14 | 2014-09-25 | The Trustees Of Columbia University In The City Of New York | Octahydropyrrolopyrroles, their preparation and use |
US9637450B2 (en) | 2013-03-14 | 2017-05-02 | The Trustees Of Columbia University In The City Of New York | Octahydrocyclopentapyrroles, their preparation and use |
EP2968304B1 (en) | 2013-03-14 | 2018-10-10 | The Trustees of Columbia University in the City of New York | 4-phenylpiperidines, their preparation and use |
WO2014151959A1 (en) | 2013-03-14 | 2014-09-25 | The Trustees Of Columbia University In The City Of New York | N-alkyl-2-phenoxyethanamines, their preparation and use |
JP6676541B2 (ja) | 2014-04-30 | 2020-04-08 | ザ・トラスティーズ・オブ・コランビア・ユニバーシティー・イン・ザ・シティー・オブ・ニューヨーク | 置換された4−フェニルピペリジン、その調製及び使用 |
JO3579B1 (ar) | 2014-09-26 | 2020-07-05 | Luc Therapeutics Inc | مُعدِلات تفاغرية سالبة لمستقبل nr2b من المركب n-ألكيل أريل-5-أوكسي أريل-ثامن هيدرو-خماسي الحلقة [c] بيرول |
DK3331886T3 (da) | 2015-08-05 | 2020-08-24 | Indivior Uk Ltd | Dopamin-d3-receptorantagonister med en bicyclo-del |
EP3744721A4 (en) | 2018-01-26 | 2021-11-10 | Shionogi & Co., Ltd | CONDENSED CYCLIC COMPOUND WITH ANTAGONISM TO DOPAMINE D3 RECEPTOR |
CN111989327A (zh) | 2018-02-05 | 2020-11-24 | 奥克梅斯公司 | 用于治疗疼痛的化合物 |
TW202108559A (zh) | 2019-05-31 | 2021-03-01 | 美商醫肯納腫瘤學公司 | Tead抑制劑及其用途 |
US11274082B2 (en) | 2019-05-31 | 2022-03-15 | Ikena Oncology, Inc. | Tead inhibitors and uses thereof |
CN114957087A (zh) * | 2022-04-13 | 2022-08-30 | 湖南复瑞生物医药技术有限责任公司 | 一种帕罗韦德中间体制备方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL110185C (ja) * | 1958-04-22 | |||
NO154582C (no) * | 1978-10-20 | 1986-11-05 | Ferrosan Ab | Analogifremgangsmaate for fremstilling av terapeutisk aktive difenyl-dibutylpiperazinkarboksamider. |
US4435419A (en) * | 1981-07-01 | 1984-03-06 | American Cyanamid Company | Method of treating depression using azabicyclohexanes |
US4605655A (en) * | 1984-03-06 | 1986-08-12 | Bristol-Myers Company | Antipsychotic 1-fluorophenylbutyl-4-(2-pyrimidinyl)piperazine derivatives |
EP0185429A1 (en) * | 1984-12-21 | 1986-06-25 | Duphar International Research B.V | New bicyclic heteroaryl piperazines |
US4994460A (en) * | 1989-06-01 | 1991-02-19 | Bristol-Myers Squibb Co. | Agents for treatment of brain ischemia |
US5055470A (en) * | 1989-06-01 | 1991-10-08 | Bristol-Myers Squibb Co. | Method of treatment of ischemia in brain |
DE4112353A1 (de) * | 1991-04-16 | 1992-10-22 | Basf Ag | 1,3,4-trisubstituierte piperidin-derivate, ihre herstellung und verwendung |
US5216018A (en) * | 1992-02-14 | 1993-06-01 | Du Pont Merck Pharmaceutical Company | Hydroisoindolines and hydroisoquinolines as psychotropic |
US5532243A (en) * | 1992-02-14 | 1996-07-02 | The Dupont Merck Pharmaceutical Company | Antipsychotic nitrogen-containing bicyclic compounds |
DE4219973A1 (de) * | 1992-06-19 | 1993-12-23 | Basf Ag | N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung |
DE4243287A1 (de) * | 1992-06-19 | 1993-12-23 | Basf Ag | N-Substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung |
-
1993
- 1993-12-04 DE DE4341403A patent/DE4341403A1/de not_active Withdrawn
-
1994
- 1994-11-26 AU AU12403/95A patent/AU680583B2/en not_active Ceased
- 1994-11-26 DE DE69425273T patent/DE69425273T2/de not_active Expired - Lifetime
- 1994-11-26 JP JP51538295A patent/JP3935201B2/ja not_active Expired - Fee Related
- 1994-11-26 WO PCT/EP1994/003913 patent/WO1995015327A1/en active IP Right Grant
- 1994-11-26 AT AT95903284T patent/ATE194620T1/de active
- 1994-11-26 BR BR9408246A patent/BR9408246A/pt not_active Application Discontinuation
- 1994-11-26 EP EP95903284A patent/EP0731802B1/en not_active Expired - Lifetime
- 1994-11-26 ES ES95903284T patent/ES2148476T3/es not_active Expired - Lifetime
- 1994-11-26 US US08/656,240 patent/US5703091A/en not_active Expired - Lifetime
- 1994-12-02 IL IL11186194A patent/IL111861A/xx not_active IP Right Cessation
- 1994-12-05 TW TW083111264A patent/TW285667B/zh active
-
1996
- 1996-06-03 FI FI962324A patent/FI113644B/fi not_active IP Right Cessation
- 1996-06-03 NO NO962286A patent/NO306346B1/no not_active IP Right Cessation
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006513256A (ja) * | 2002-08-14 | 2006-04-20 | アボット・ラボラトリーズ | 中枢神経系活性剤であるアザビシクロ化合物 |
JP2008535886A (ja) * | 2005-04-14 | 2008-09-04 | グラクソ グループ リミテッド | ドーパミンd3受容体のモジュレーターとしての3−(1,2,4−トリアゾール−3−イルアルキル)アザビシクロ(3.1.0)ヘキサン誘導体 |
JP2013542929A (ja) * | 2010-09-28 | 2013-11-28 | パナセア バイオテック リミテッド | 新規ビシクロ環化合物 |
JP2016536348A (ja) * | 2013-09-26 | 2016-11-24 | ラック・セラピューティクス,インコーポレーテッド | Nr2bの選択的オクタヒドロ−シクロペンタ[c]ピロール負調節因子 |
US11116749B2 (en) | 2013-09-26 | 2021-09-14 | Cadent Therapeutics, Inc | Selective octahydro-cyclopenta[c]pyrrole negative modulators of NR2B |
WO2018021447A1 (ja) * | 2016-07-28 | 2018-02-01 | 塩野義製薬株式会社 | ドーパミンd3受容体拮抗作用を有する含窒素縮環化合物 |
JPWO2018021447A1 (ja) * | 2016-07-28 | 2019-05-23 | 塩野義製薬株式会社 | ドーパミンd3受容体拮抗作用を有する含窒素縮環化合物 |
Also Published As
Publication number | Publication date |
---|---|
BR9408246A (pt) | 1997-05-27 |
EP0731802B1 (en) | 2000-07-12 |
ATE194620T1 (de) | 2000-07-15 |
TW285667B (ja) | 1996-09-11 |
US5703091A (en) | 1997-12-30 |
DE69425273T2 (de) | 2001-01-18 |
NO306346B1 (no) | 1999-10-25 |
ES2148476T3 (es) | 2000-10-16 |
NO962286L (no) | 1996-06-03 |
FI962324A (fi) | 1996-06-03 |
WO1995015327A1 (en) | 1995-06-08 |
AU1240395A (en) | 1995-06-19 |
AU680583B2 (en) | 1997-07-31 |
FI113644B (fi) | 2004-05-31 |
FI962324A0 (fi) | 1996-06-03 |
IL111861A (en) | 1999-08-17 |
DE4341403A1 (de) | 1995-06-08 |
EP0731802A1 (en) | 1996-09-18 |
DE69425273D1 (de) | 2000-08-17 |
IL111861A0 (en) | 1995-03-15 |
JP3935201B2 (ja) | 2007-06-20 |
NO962286D0 (no) | 1996-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH09506346A (ja) | 神経弛緩薬afsとしてのn−置換されたアザビシクロアルカン誘導体 | |
DE60113865T2 (de) | Piperazin derivate | |
EP0708101B1 (fr) | Dérivés de pipéridine utiles comme antagonistes des récepteurs des neurokinines | |
US5399562A (en) | Indolones useful as serotonergic agents | |
US7399779B2 (en) | 3,6-disubstituted azabicyclo [3.1.0] hexane derivatives useful as muscarinic receptor antagonists | |
TW200800205A (en) | Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) | |
JPH0753731B2 (ja) | 複素環式キノキサリン化合物、その製造方法並びその用途 | |
WO1994000454A1 (en) | Benzimidazole compounds | |
SK281938B6 (sk) | Indolové deriváty, spôsob ich prípravy, medziprodukty pri postupe ich výroby, farmaceutické prostriedky obsahujúce tieto deriváty a použitie týchto derivátov | |
EP0647231A1 (de) | N-substituierte 3-azabicyclo 3.2.0]heptanderivate als neuroleptika usw. | |
AU2004228452A2 (en) | Azabicyclo derivatives as muscarinic receptor antagonists | |
EP2294068A1 (fr) | DERIVES DE 1,3-DIHYDRO-2H-PYRROLO(3,2-b) PYRIDIN-2-ONE, LEUR PREPARATION ET LEURS APPLICATIONS EN THERAPEUTIQUE | |
US5908844A (en) | N-substituted azabicycloalkane derivatives, their preparation and use | |
EP0740658B1 (de) | N-substituierte azabicycloheptan-derivate und ihre verwendung, z.b., als neuroleptika | |
BG63633B1 (bg) | N-заместени 3-азабицикло(3.2.0) хептанови производни, метод за получаване и използването им | |
JP2865255B2 (ja) | 1,2,3,4,10,14b‐ヘキサヒドロジベンゾ〔c,f〕ピラジノ〔1,2‐a〕アゼピノ誘導体及び10‐アザ,10‐オキサ及び10‐チア類似体 | |
US5521193A (en) | Benzimidazole compounds | |
JPH05504358A (ja) | 置換尿素化合物及びそれらの製法及び使用 | |
JPH07509242A (ja) | 5−htアゴニストまたはアンタゴニストとしての1−アザアダマンタン誘導体 | |
KR20060096038A (ko) | 3-아자비시클로〔3.1.0〕헥산 유도체의 제조법 | |
JP2023536197A (ja) | 薬理学的に活性な複素環式置換されたピラゾロ[1,5-a]ピリミジン誘導体 | |
US5534521A (en) | Benzimidazole compounds | |
EP2189451A1 (en) | Benzamide derivatives, their preparation and uses in medicine thereof | |
US5530018A (en) | Meso-azanoradamantanes | |
CA2177602C (en) | N-substituted azabicycloalkane derivatives, their preparation and use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20040209 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20040322 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040511 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060228 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20060526 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20060710 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060828 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20070220 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20070319 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100330 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110330 Year of fee payment: 4 |
|
LAPS | Cancellation because of no payment of annual fees |